Page Tools:
  • print-friendly version

Progress in Oncology 2004

Author(s): Vincent T. DeVita Jr., MD, Yale University School of Medicine, New Haven, Connecticut
Samuel Hellman, MD, University of Chicago Pritzker School of Medicine, Chicago, Illinois
Steven A. Rosenberg, MD, PhD, National Cancer Institute
Details:
  • ISBN-13: 9780763745783
  • ISBN-10:0763745782
  • Hardcover    360 pages      © 2005
Price: International Sales $188.95 US List
Add to Cart

Overview

The fourth volume in this outstanding series of annual updates in oncology, Progress in Oncology 2004 addresses fifteen of the most important “hot topics” in the field. Under the careful direction of Drs. DeVita, Hellman, and Rosenberg, each volume in this exciting series presents concise summaries of the state of the art in cancer basic science and clinical application, written by 15 of the top researchers and clinicians in the world.

As with all the volumes in the series, PIO 2004 covers critical issues in clinical cancer care and research in a scholarly though readable style. Chapters on advances in treatment and diagnosis, including DNA microarrays, growth factor receptors, new applications of thalidomide, and allografting in NHL review the state of the art in these emerging fields. Top experts provide timely overviews of focused ultrasound therapy, hormone therapy for prostate cancer, and CHOP and rituxin for DLCL. In a special surgery section, world-class authorities discuss approaches to rectal cancer. These and other rigorously referenced chapters make PIO 2004 an indispensable new oncology resource.

ShowTable of Contents

Chapter 1.  The Varied Applications of Small Interference RNA ~ Udit N. Verma

Chapter 2.  Microarray Analysis of Sarcomas ~ Braden Greer and Javed Khan

Chapter 3.  ErbB/HER Family of Growth Factor Receptors ~ Noa Ben-Baruch and Yosef Yarden

Chapter 4.  Targeting the Epidermal Growth Factor Receptor in the Clinic ~ Amir Onn, John Mendelsohn, and Roy S. Herbst

Chapter 5.  Histone Acetyltransferases and Histone Deacetylases in Gene Regulation and as Drug Targets ~ Steven G. Gray

Chapter 6.  Role of DNA Hypomethylating Agents in Cancer Treatment ~ Guillermo Garcia-Manero and Jean-Pierre J. Issa

Chapter 7.  New Applications for Thalidomide in the Treatment of Patients with Solid Cancer ~ Robert J. Amato

Chapter 8.  New Approaches to Allografting in Non-Hodgkin’s Lymphoma ~ Stuart Seropian and Dennis Cooper

Chapter 9.  Clinical Applications of Molecular Profiling in Lymphomas ~ Kieron Dunleavy, Louis Staudt, and Wyndham H. Wilson

Chapter 10.  Chemotherapy Combined with Monoclonal Antibodies in the Treatment of Patients with Diffuse Large B-cell Lymphoma ~ Bertrand Coiffier

Chapter 11.  Novel Schedules of Hormone Therapy for Prostate Cancer ~ James Gulley and William L. Dahut

Chapter 12.  The Immunotherapy of Patients with Metastatic Melanoma by Inducing Clonal Repopulation with Antitumor Lymphocytes ~ Steven A. Rosenberg and Mark E. Dudley

Chapter 13.  Focused Ultrasound for the Treatment of Patients with Cancer ~ Kullervo Hynynen and Nathan McDannold

Chapter 14.  The Concept of Dose Density and its Application to the Adjuvant Chemotherapy of Node-Positive Primary Breast Cancer ~ Larry Norton and Clifford Hudis

Chapter 15.  Current Status of Total Mesorectal Excision for Rectal Cancer ~ Joseph Martz, Vicki Brooks, and Warren E. Enker


Back to top

ShowAbout the Author(s)

Vincent T. DeVita Jr., MD-Yale University School of Medicine, New Haven, Connecticut

Dr. DeVita is Professor of Medicine and Professor of Epidemiology and Public Health at the Yale University School of Medicine in New Haven, CT. He is the former Director of the National Cancer Institute and developed the cure for Hodgkin's Disease and other lymphomas. He is the Director Emeritus at the Yale Cancer Center and has received numerous awards including the Mary and Albert Lasker Prize, the Medal of Honor from the American Cancer Society, the first Pezcoller Award from the European School of Oncology, the Armand Hammer Cancer Prize and the Surgeon General's Exemplary Service Medal. He recently was recognized with the 50th Anniversary Commemorative Award from the Leukemia Society of America and was the recipient of the first Saul Rosenberg Research Award from the Lymphoma Research Foundation of America. Dr. DeVita also served as co-chair of the National Cancer Legislative Advisory Committee for revising the National Cancer Act of 1971.

Additional Titles by this Author

Samuel Hellman, MD-University of Chicago Pritzker School of Medicine, Chicago, Illinois

In the course of his career as a practitioner, teacher, investigator and leader in radiation oncology, Samuel Hellman, M.D., has advanced his specialty in too many ways to count. Although he is perhaps best known for advancing cancer treatment with his groundbreaking clinical research on malignant lymphomas and breast cancer, Dr. Hellman’s accomplishments at the institutions he served and with the students he mentored also have transformed and elevated the role of radiation oncology.  As a member of numerous external advisory committees, cancer-center boards, and research funding agencies, Dr. Hellman is a powerful advocate for radiology and the radiological sciences. 

 

Steven A. Rosenberg, MD, PhD-National Cancer Institute

Dr. Rosenberg received his B.A. and M.D. from the Johns Hopkins University, and he received a Ph.D. in biophysics from Harvard University. Following the completion of his surgical residency at the Peter Bent Brigham Hospital in Boston, MA, Dr. Rosenberg became chief of the Surgery Branch at the National Cancer Institute, Bethesda, MD in July 1974, a position he continues to hold now. His research interests have focused on studies of tumor immunology and the development of effective immunotherapies for the treatment of patients with cancer.

 

Back to top